id
name
related bits
0
processing priority
4
site type
0 (generic, awaiting analysis)
review version
11
html import
20 (imported)
first seen date
2024-02-02 00:53:48
expired found date
-
created at
2024-06-21 16:50:59
updated at
2026-01-20 05:02:15
length
15
crc
50728
tld
2211
nm parts
0
nm random digits
0
nm rare letters
0
is subdomain of id
-
previous id
0
replaced with id
0
related id
-
dns primary id
dns alternative id
0
lifecycle status
0 (unclassified, or currently active)
deleted subdomains
0
page imported products
0
page imported random
0
page imported parking
0
count skipped due to recent timeouts on the same server IP
0
count content received but rejected due to 11-799
0
count dns errors
0
count cert errors
0
count timeouts
0
count http 429
0
count http 404
0
count http 403
0
count http 5xx
0
next operation date
-
server bits
—
server ip
-
mp import status
20
mp rejected date
-
mp saved date
-
mp size orig
215126
mp size raw text
4117
mp inner links count
2
mp inner links status
20 (imported)
title
CRISPR/Cas9 Gene Editing & Patent Licensing | ERS Genomics
description
ERS Genomics is the global leader in providing access to foundational patents covering CRISPR/Cas9 intellectual property and licencing.
site name
ERS Genomics
author
updated
2025-12-30 20:34:05
raw text
CRISPR/Cas9 Gene Editing & Patent Licensing | ERS Genomics Skip to navigation Skip to content MENU CRISPR/Cas9 Intellectual Property Licensing Knowledge Centre News Our Team Contact Us The global CRISPR/Cas9 licensing leader Based on the Nobel Prize winning invention of Emmanuelle Charpentier & Jennifer Doudna, CRISPR/Cas9 has transformed gene editing. ERS licenses worldwide access to the essential CRISPR/Cas9 patent portfolio. Contact us "This is transformative technology that allows the recoding of life and editing" Emmanuelle Charpentier ERS co-founder, patent co-owner & 2020 Nobel prize winner The essential intellectual property for the practice of CRISPR/Cas9 Consisting of over 85 issued patents in over 80 countries, our portfolio represents the most foundational collection of CRISPR/Cas9 patents worldwide. Learn more Latest news ERS Genomics and StemSight sign CRISPR/Cas9 license agreement Posted on 17 Janua...
redirect type
31 (document.location)
block type
0 (no issues)
detected language
1 (English)
category id
Other [en] (231)
index version
2025123101
spam phrases
0
text nonlatin
0
text cyrillic
0
text characters
3082
text words
541
text unique words
215
text lines
93
text sentences
18
text paragraphs
10
text words per sentence
30
text matched phrases
0
text matched dictionaries
0
links self subdomains
0
links other subdomains
links other domains
4 - themedicinemaker.com, eggdesign.ie, wpdownloadmanager.com
links spam adult
0
links spam random
0
links spam expired
0
links ext activities
1
links ext ecommerce
0
links ext finance
0
links ext crypto
0
links ext booking
0
links ext news
0
links ext leaks
0
links ext ugc
links ext klim
0
links ext generic
3
dol status
0
dol updated
2025-12-30 20:34:05
rss path
rss status
32 (unknown)
rss found date
2024-02-02 07:35:37
rss size orig
40360
rss items
10
rss spam phrases
0
rss detected language
1 (English)
inbefore feed id
-
inbefore status
0 (new)
sitemap path
sitemap status
34 (reserved: import paused pending content quality/relevance assessment after importing first 500 pages)
sitemap review version
2
sitemap urls count
212
sitemap urls adult
0
sitemap filtered products
0
sitemap filtered videos
0
sitemap found date
2024-02-02 00:53:48
sitemap process date
2024-11-25 19:17:01
sitemap first import date
-
sitemap last import date
2026-01-20 05:02:15